Advances in cancer genomics

Reprint of: Cytogenetic and Genome Research 2016, Vol. 150, No. 3-4 The last special issue of Cytogenetics and Genome Research on Cancer Genomics was published in 2007. Since then, there have been astonishing developments in the fields of molecular genetics and translational medicine. Clinical and r...

Full description

Saved in:
Bibliographic Details
Other Authors: Cannizzaro, Linda A. (Editor)
Format: Book
Language:English
Published: Basel S. Karger AG 2017
Subjects:
Online Access:Click Here to View Status and Holdings.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nam a2200000#i 4501
001 wils-929305
005 2018715111423
008 211213t20172017 SZ a## # 0 deng D
020 # # |a 9783318060454  |q hardback 
020 # # |a 3318060453  |q hardback 
040 # # |a UiTM  |e rda 
041 0 # |a English 
060 0 0 |a QZ 210 
090 0 0 |a QZ210  |b A2444 2017 
245 0 0 |a Advances in cancer genomics  |c edited by Linda A. Cannizzaro 
264 # 1 |a Basel  |b S. Karger AG  |c 2017 
264 # 4 |c ©2017 
300 # # |a iv, 134 pages  |b illustration  |c 29 cm 
336 # # |a text  |b txt  |2 rdacontent 
337 # # |a unmediated  |b n  |2 rdamedia 
338 # # |a volume  |b nc  |2 rdacarrier 
500 # # |a Reprint of Cytogenetic and genome research vol. 150, no. 3-4,2016 
504 # # |a Includes bibliographical references and index 
520 # # |a Reprint of: Cytogenetic and Genome Research 2016, Vol. 150, No. 3-4 The last special issue of Cytogenetics and Genome Research on Cancer Genomics was published in 2007. Since then, there have been astonishing developments in the fields of molecular genetics and translational medicine. Clinical and research investigations have shown that the cytogenetic and molecular genomic abnormalities in hematologic and solid tumor malignancies are specific to manifestation of disease development and progression. However, the heterogeneous nature of these genomic alterations has hindered understanding of their significance as the malignant state evolves and of their impact on survival and remission after treatment. The introduction of high-resolution technologies has helped to unravel the complexity of many cancer-associated genomic alterations. Studies like array comparative hybridization (aCGH), single nucleotide polymorphism analyses (SNP), next-generation sequencing (NGS), and gene expression analyses (GEP), have facilitated a more thorough understanding of the pathology of hematologic and solid tumor neoplasms. This issue contains representative articles to further knowledge of the manifestation and progression of cancer. It adds to the ongoing efforts to ultimately create personalized treatments and to eventually eliminate the devastation of malignancy in patients 
650 1 2 |a Cancer  |x Genetic aspects 
700 1 # |a Cannizzaro, Linda A.  |e editor 
856 4 0 |z Click Here to View Status and Holdings.  |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=929305